Similar Adiponectin Levels in Obese Normotensive and Obese Hypertensive Men and No Vasorelaxant Effect of Adiponectin on Human Arteries
暂无分享,去创建一个
J. Jeppesen | A. Linneberg | J. Frystyk | L. Edvinsson | A. Flyvbjerg | C. Asferg | U. Andersen | J. O. Berg | G. Skovsted | R. Dreier | Gry F. Skovsted
[1] C. Mantzoros,et al. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. , 2015, Metabolism: clinical and experimental.
[2] A. Heagerty,et al. Mechanisms of adiponectin-associated perivascular function in vascular disease. , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[3] G. Limongelli,et al. Adipose tissue and vascular inflammation in coronary artery disease. , 2014, World journal of cardiology.
[4] J. Jeppesen,et al. Overweight, adipocytokines and hypertension: a prospective population-based study , 2014, Journal of hypertension.
[5] Haiming Cao. Adipocytokines in obesity and metabolic disease. , 2014, The Journal of endocrinology.
[6] M. Schulze,et al. Adiponectin and Risk of Stroke: Prospective Study and Meta-analysis , 2014, Stroke.
[7] T. Funahashi,et al. Adiponectin as a routine clinical biomarker. , 2014, Best practice & research. Clinical endocrinology & metabolism.
[8] R. Goldberg,et al. Clinical use of adiponectin as a marker of metabolic dysregulation. , 2014, Best practice & research. Clinical endocrinology & metabolism.
[9] C. Apovian,et al. Insulin status and vascular responses to weight loss in obesity. , 2013, Journal of the American College of Cardiology.
[10] Y. Kang. Obesity Associated Hypertension: New Insights into Mechanism , 2013, Electrolyte & blood pressure : E & BP.
[11] J. van de Voorde,et al. Adipocytokines in relation to cardiovascular disease. , 2013, Metabolism: clinical and experimental.
[12] V. Rovella,et al. Obesity-Related Metabolic Syndrome: Mechanisms of Sympathetic Overactivity , 2013, International journal of endocrinology.
[13] Preserved endothelial function in human obesity in the absence of insulin resistance , 2013, Journal of Translational Medicine.
[14] A. Heagerty,et al. Stimulated release of a hyperpolarizing factor (ADHF) from mesenteric artery perivascular adipose tissue: involvement of myocyte BKCa channels and adiponectin , 2013, British journal of pharmacology.
[15] Eugene Kim,et al. Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. , 2013, International journal of epidemiology.
[16] A. Yoshida,et al. Adiponectin-induced dilation of isolated porcine retinal arterioles via production of nitric oxide from endothelial cells. , 2013, Investigative ophthalmology & visual science.
[17] L. Kappelle,et al. Adiponectin and incident coronary heart disease and stroke. A systematic review and meta‐analysis of prospective studies , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[18] J. Jeppesen,et al. Relative Atrial Natriuretic Peptide Deficiency and Inadequate Renin and Angiotensin II Suppression in Obese Hypertensive Men , 2013, Hypertension.
[19] M. Caulfield,et al. Genes for blood pressure: an opportunity to understand hypertension. , 2013, European heart journal.
[20] Matthias E. Werner,et al. Perivascular adipose tissue-derived adiponectin activates BK(Ca) channels to induce anticontractile responses. , 2013, American journal of physiology. Heart and circulatory physiology.
[21] S. Hama,et al. Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and restoration of normal anticontractile activity despite persistent obesity , 2013, The Lancet.
[22] H. Randeva,et al. Role of adipokines in cardiovascular disease. , 2013, The Journal of endocrinology.
[23] Y. Matsuzawa,et al. Adiponectin and hypertension. , 2011, American journal of hypertension.
[24] G. Jensen,et al. Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study. , 2010, American journal of hypertension.
[25] A. Heagerty,et al. Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients , 2009, Circulation.
[26] S. Blair,et al. Body mass index as a predictor of hypertension incidence among initially healthy normotensive women. , 2008, American journal of hypertension.
[27] P. Scherer,et al. Adiponectin, Cardiovascular Function, and Hypertension , 2008, Hypertension.
[28] M. Gollasch,et al. Adiponectin is a novel humoral vasodilator. , 2007, Cardiovascular research.
[29] T. Lam,et al. Hypoadiponectinemia as a Predictor for the Development of Hypertension: A 5-Year Prospective Study , 2007, Hypertension.
[30] J. Frystyk,et al. Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. , 2007, The Journal of clinical endocrinology and metabolism.
[31] C. Block,et al. Mechanisms linking obesity with cardiovascular disease , 2006, Nature.
[32] L. Campbell,et al. The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. , 2005, European journal of endocrinology.
[33] H. Parving,et al. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications , 2005, Diabetologia.
[34] M. Suchard,et al. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Ogihara,et al. Hypoadiponectinemia Is an Independent Risk Factor for Hypertension , 2004, Hypertension.
[36] P. Arner,et al. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. , 2004, The Journal of clinical endocrinology and metabolism.
[37] A. Xu,et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. , 2004, The Journal of clinical endocrinology and metabolism.
[38] Hui Chen,et al. Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells* , 2003, Journal of Biological Chemistry.
[39] T. Funahashi,et al. Plasma adiponectin concentration before and after successful kidney transplantation. , 2003, Transplantation proceedings.
[40] T. Funahashi,et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. , 2003, The Journal of clinical endocrinology and metabolism.
[41] G. Sesti,et al. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. , 2003, Diabetes care.
[42] T. Funahashi,et al. Decreased plasma adiponectin concentration in patients with essential hypertension. , 2003, American journal of hypertension.
[43] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[44] S. Kihara,et al. Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.
[45] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[46] T Nakamura,et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.
[47] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[48] 李俊熈. 腰痛発生の危険因子5-year prospective study , 1999 .
[49] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.